Search
Pratosartan
go.drugbank.com/drugs/DB20100ExperimentalThe usage of the INN stem '-sartan' in the name indicates that Pratosartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).
Ketazocine
go.drugbank.com/drugs/DB20132ExperimentalThe usage of the INN stem '-azocine' in the name indicates that Ketazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan. Ketazocine has a monoisotopic molecular weight of 285.17 Da.
Ripisartan
go.drugbank.com/drugs/DB20229ExperimentalThe usage of the INN stem '-sartan' in the name indicates that Ripisartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).
Tribenoside
go.drugbank.com/drugs/DB13227InvestigationalAnti-inflammatory agent used in edema of extremities, varicose veins & phlebitis.
Categories: Analgesics, Non-NarcoticTeceleukin
go.drugbank.com/drugs/DB15389InvestigationalTeceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
Categories: Analgesics, Non-NarcoticAllisartan isoproxil
go.drugbank.com/drugs/DB18880InvestigationalAllisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes).
Categories: Agents Acting on the Renin-Angiotensin SystemEltoprazine
go.drugbank.com/drugs/DB12883InvestigationalEltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeSt. John's Wort
go.drugbank.com/drugs/DB01323ApprovedInvestigationalNutraceuticalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeTMC-649128
go.drugbank.com/drugs/DB15152InvestigationalTMC-649128 is under investigation in clinical trial NCT01391117 (TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics